Autonomous artificial intelligence prescribing a drug to prevent severe acute graft-versus-host disease in HLA-haploidentical transplants

Autonomous artificial intelligence (AI) models for deciding treatment strategies are available but rarely applied prospectively in clinical settings. Here we present a prospective study of deploying daGOAT, an algorithm we have developed, as a conditional autonomous AI agent to prescribe a drug to prevent severe (grade 3-4) acute graft-versus-host disease (acute GvHD) following human leukocyte antigen (HLA)-mismatched haematopoietic cell transplantation (ClinicalTrials.gov, NCT05600855). During the enrollment period physicians invite 85% of eligible patients to participate and 88% of the invited patients agree. Among the 110 enrolled participants who receive HLA-haploidentical transplants, daGOAT predicts intermediate to high risk of severe acute GvHD in 57 participants between days +17 and +23 posttransplant and prescribes ruxolitinib in addition to the existing regimen to intensify immune suppression. The initial compliance with AI prescription is 98% (56/57), with dose and/or schedule deviating from the AI prescription within one month in a total of eight participants. In conclusion, we show that many physicians and patients are receptive to using conditional autonomous AI to prescribe a drug and that the decision for pharmaceutical intervention could be facilitated by autonomous AI.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2025-09-25
DOI
https://doi.org/10.1038/s41467-025-62926-0
Citations
2
Primary Topic
Artificial Intelligence in Healthcare
Type
article
Field-Weighted Citation Impact
5.88

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Autonomous artificial intelligence prescribing a drug to prevent severe acute graft-versus-host disease in HLA-haploidentical transplants

Mingzhe Han, Xiaowen Gong, Xueqian Li, Sichang Liu et al.
2 citations
Nature Communications
Artificial Intelligence in Healthcare
5.88
article

Autonomous artificial intelligence prescribing a drug to prevent severe acute graft-versus-host disease in HLA-haploidentical transplants

Mingzhe Han, Xiaowen Gong, Xueqian Li, Sichang Liu, Saibing Qi, Junren Chen, Xiaofan Zhu, Qiujin Shen, Erlie Jiang, Mingming Niu, Yiguo Hu, Xueou Liu, Rongli Zhang, Jialin Wei, Mengyun Chen, Sizhou Feng, Xianfeng Shao, Xianjing Zhang, Jieya Luo, Donglin Yang, Ye Guo, Wanying Zhai, Aiming Pang, Mingyang Wang, Hong Wang, Wei Zhang, Pan Pan, Yan Wen, Ningning Zhao, Dong Zhang, Ruixin Li, Mingjun Xu, Xiaolin Zhai, Liang Chen, Yahui Feng, Robert Peter Gale, Zhen Song, Weihua Zhai, Yigeng Cao, Yu Xu
article en
2 citations

Abstract

Autonomous artificial intelligence (AI) models for deciding treatment strategies are available but rarely applied prospectively in clinical settings. Here we present a prospective study of deploying daGOAT, an algorithm we have developed, as a conditional autonomous AI agent to prescribe a drug to prevent severe (grade 3-4) acute graft-versus-host disease (acute GvHD) following human leukocyte antigen (HLA)-mismatched haematopoietic cell transplantation (ClinicalTrials.gov, NCT05600855). During the enrollment period physicians invite 85% of eligible patients to participate and 88% of the invited patients agree. Among the 110 enrolled participants who receive HLA-haploidentical transplants, daGOAT predicts intermediate to high risk of severe acute GvHD in 57 participants between days +17 and +23 posttransplant and prescribes ruxolitinib in addition to the existing regimen to intensify immune suppression. The initial compliance with AI prescription is 98% (56/57), with dose and/or schedule deviating from the AI prescription within one month in a total of eight participants. In conclusion, we show that many physicians and patients are receptive to using conditional autonomous AI to prescribe a drug and that the decision for pharmaceutical intervention could be facilitated by autonomous AI.

Nature CommunicationsVol. 16(1)
Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Tianjin Academy of Fine Arts (CN), Tianjin Anding Hospital (CN), Institute of Hematology & Blood Diseases Hospital (CN), Tianjin Metallurgical Vocational Technical College (CN), Imperial College London (GB)
National Institute for Health and Care Research, National Natural Science Foundation of China, Chinese Academy of Medical Sciences, Natural Science Foundation of Tianjin City, Tianjin Science and Technology Committee, Fundamental Research Funds for the Central Universities
Openalex Percentile: Top 3%
Artificial Intelligence in Healthcare
5.88
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.